UFF
AMED

USA Financial Formulas’s Amedisys AMED Stock Holding History

USA Financial Formulas’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,575
Closed -$462K – 331
2020
Q4 		$462K Sell
1,575
-894
-36% -$229K 0.37% 79
2020
Q3 		$584K Buy
+2,469
New +$561K 0.44% 64
2019
Q1 		– Sell
-7,852
Closed -$981K – 130
2018
Q4 		$981K Buy
+7,852
New +$925K 0.24% 69
2015
Q3 		– Sell
-10,257
Closed -$408K – 100
2015
Q2 		$408K Sell
10,257
-155
-1% -$4.83K 0.13% 156
2015
Q1 		$279K Sell
10,412
-5,998
-37% -$169K 0.09% 157
2014
Q4 		$482K Buy
+16,410
New +$405K 0.17% 110

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

USA Financial Formulas's AMED Position: Q1 2021 in Review

USA Financial Formulas sold out of Amedisys (AMED) in Q1 2021, closing a stake of 1,575 shares — an estimated $462K sold.

USA Financial Formulas first reported a position in AMED in Q4 2014 and held it in 6 quarters. The position peaked at $981K in Q4 2018. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • USA Financial Formulas reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • USA Financial Formulas sold 1,575 Amedisys shares in Q1 2021, an estimated $462K.
  • USA Financial Formulas first reported a position in Amedisys in Q4 2014 and held it in 6 quarters.
  • USA Financial Formulas's Amedisys position peaked at $981K in Q4 2018.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on USA Financial Formulas's 13F filing for Q1 2021, filed 6 May 2021.